Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation – towards oral insulin delivery
暂无分享,去创建一个
[1] R. Knott,et al. Synthesis, characterisation and in vitro evaluation of novel thiolated derivatives of polyallylamine and quaternised polyallylamine , 2015, Colloid and Polymer Science.
[2] C. Ibie,et al. In-vitro evaluation of the effect of polymer structure on uptake of novel polymer-insulin polyelectrolyte complexes by human epithelial cells. , 2015, International journal of pharmaceutics.
[3] C. Ibie,et al. The oral delivery of proteins using interpolymer polyelectrolyte complexes. , 2011, Therapeutic delivery.
[4] Chandra P Sharma,et al. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. , 2010, Acta biomaterialia.
[5] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[6] K. Bouchemal,et al. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] L. Tetley,et al. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery. , 2010, International journal of pharmaceutics.
[8] Lichen Yin,et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. , 2009, Biomaterials.
[9] V. Jarm. Terminology of Polymers Containing Ionizable or Ionic Groups and of Polymers Containing Ions, VII.3 , 2009 .
[10] L. Tetley,et al. The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery. , 2009, International journal of pharmaceutics.
[11] E. Arbit,et al. Oral Insulin: The Rationale for This Approach and Current Developments , 2009, Journal of diabetes science and technology.
[12] Wenjie Zhu,et al. Improving the Stability of Insulin in Solutions Containing Intestinal Proteases in Vitro , 2008, International journal of molecular sciences.
[13] L. Tetley,et al. The effect of polymer architecture on the nano self-assemblies based on novel comb-shaped amphiphilic poly(allylamine) , 2008 .
[14] B Larijani,et al. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[15] Q. Ping,et al. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. , 2008, International journal of pharmaceutics.
[16] Shirui Mao,et al. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. , 2007, International journal of pharmaceutics.
[17] D. Fischer,et al. Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells , 2005, Pharmaceutical Research.
[18] David J Brayden,et al. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. , 2005, Drug discovery today.
[19] Elias Fattal,et al. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] A. Bernkop‐Schnürch,et al. Thiomers: potential excipients for non-invasive peptide delivery systems. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] T. Kissel,et al. Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)- propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft- poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides. , 2004, Bioconjugate chemistry.
[22] A. Bernkop‐Schnürch,et al. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. , 2003, International journal of pharmaceutics.
[23] J. Hamman,et al. N-Trimethyl Chitosan Chloride: Optimum Degree of Quaternization for Drug Absorption Enhancement Across Epithelial Cells , 2003, Drug development and industrial pharmacy.
[24] A. Cherrington,et al. Direct and indirect effects of insulin on glucose uptake and storage by the liver. , 2002, Diabetes.
[25] J. Hamman,et al. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. , 2002, International journal of pharmaceutics.
[26] N. Shibata,et al. Absorption Enhancing Effect of Labrasol on the Intestinal Absorption of Insulin in Rats , 2002, Journal of drug targeting.
[27] H. Junginger,et al. Oral drug absorption enhancement by chitosan and its derivatives. , 2001, Advanced drug delivery reviews.
[28] L. Tetley,et al. The Level of Hydrophobic Substitution and the Molecular Weight of Amphiphilic Poly-L-lysine-Based Polymers Strongly Affects Their Assembly into Polymeric Bilayer Vesicles. , 2001, Journal of colloid and interface science.
[29] B. Tiersch,et al. Polyelectrolyte-induced vesicle formation in lamellar liquid-crystalline model systems , 2000 .
[30] Carino,et al. Oral insulin delivery. , 1999, Advanced drug delivery reviews.
[31] H. Dautzenberg. Polyelectrolyte Complex Formation in Highly Aggregating Systems. 1. Effect of Salt: Polyelectrolyte Complex Formation in the Presence of NaCl , 1997 .
[32] A. Fasano,et al. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. , 1997, The Journal of clinical investigation.
[33] J. Fix. Oral Controlled Release Technology for Peptides: Status and Future Prospects , 1996, Pharmaceutical Research.
[34] R. Borchardt,et al. Structural requirements for intestinal absorption of peptide drugs , 1996 .
[35] A. Mitra,et al. Degradation of Insulin by Trypsin and Alpha-Chymotrypsin , 1991, Pharmaceutical Research.
[36] Josias H. Hamman,et al. Oral Delivery of Peptide Drugs , 2012, BioDrugs.
[37] T. Kitayama,et al. Terminology of polymers containing ionizable or ionic groups and of polymers containing ions (IUPAC Recommendations 2006) , 2006 .
[38] J. Hamman,et al. Oral delivery of peptide drugs: barriers and developments. , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.
[39] T. Radeva,et al. Polyelectrolyte complex formation in highly aggregating systems: Methodical aspects and general tendencies. , 2001 .
[40] R. Narayani. ORAL DELIVERY OF INSULIN- MAKING NEEDLES NEEDLESS , 2001 .
[41] K. P. Rao,et al. Hypoglycemic Effect of Gelatin Microspheres with Entrapped Insulin and Protease Inhibitor in Normal and Diabetic Rats , 1995 .